Cancer is Far from an Equal-Opportunity Killer

Guest Author
Guest Author
· 3 min read

Dr Poonam Khetrapal Singh, WHO Regional Director for South-East Asia

Cancer is far from an equal-opportunity killer. In 2018 – 18.1 million new cases developed worldwide, while around 9.6 million people died from the disease. 70% of those deaths occurred in low and middle-income countries, including those of the WHO South-East Asia Region.

Inadequate access to cancer screening, diagnosis and treatment is the primary cause. In 2017 just 30% of low-income countries reported having appropriate cancer treatment services available. That compares to more than 90% of high-income countries. Just 26% of low-income countries meanwhile reported having pathology services generally available in the public sector, leading to late diagnosis and a lower chance of successful treatment.

Member States Region-wide have taken action. As early as 2015 the Regional Committee adopted a resolution on the way forward for cancer prevention and control, emphasizing the need to strengthen national programmes. That commitment was fortified in 2017, when the World Health Assembly adopted a resolution that promoted an integrated approach to providing cancer services, and when in 2018 the WHO Global Initiative for Childhood Cancer was launched.

To accelerate Region-wide progress and counter the fact that more than 67% of the Region’s cancer patients die before the age of 70, several core initiatives must be strengthened.

Of pressing need is integrating national cancer control programmes into health systems at every level. While tertiary services are important, they are expensive and generally most effective when a cancer is detected early. To make that happen, effective cancer screening services must be available at both secondary and primary facilities, while health workers must be trained to identify the signs and symptoms that could lead to a positive diagnosis.

Member States should also continue to implement policies that prioritize cancer prevention across sectors. That could mean pursuing the plain-packaging of tobacco products (tobacco is the single largest cause of cancer, making up around 22% of cancer deaths), better regulating alcohol consumption or promoting the virtues of a healthy diet and active lifestyle. It could also mean strengthening immunization programmes to ensure everyone receives the hepatitis B vaccine and all females receive the human papilloma virus vaccine.

Importantly, and as the theme of this year’s World Cancer Day – ‘I am and I will’ – emphasizes, each of us can be a changemaker. By avoiding behaviors that are linked to cancer we can reduce our own risk while encouraging our peers to do the same. Notably, we can also promote high-level engagement and funding of national programmes. As a 2014 World Health Assembly resolution urges, beyond prevention and control, this should include promoting quality palliative services able to give terminal patients the care and dignity they deserve.

WHO is committed to working with Member States to strengthen cancer prevention and control programmes Region-wide. Doing so is commensurate with the Region’s Flagship Priorities on tackling noncommunicable diseases, as well as achieving universal health coverage. It is also commensurate with the conviction that people in low- and middle-income countries should be at no greater risk of cancer and associated mortality than those anywhere else in the world.

Read Next

Focal One Robotic HIFU: Precision Treatment Revolutionizes Prostate Cancer Care in India
Featured Article
May 5, 2026

Focal One Robotic HIFU: Precision Treatment Revolutionizes Prostate Cancer Care in India

Dr Himesh Gandhi, Consultant Uro-oncologist and Director of Robotic Surgery at Ruby Hall Clinic, highlights how Ruby Hall Clinic’s new Focal One Robotic HIFU system targets only cancerous prostate tissue, sparing healthy areas to minimize incontinence and erectile dysfunction. This precision therapy offers day-care procedures and rapid recovery for India’s rising prostate cancer cases, bridging the gap between […]
Article by: Sony Singh
Predictive Healthcare: How AI is Shifting from Detection to Prevention in India
Featured Article
April 29, 2026

Predictive Healthcare: How AI is Shifting from Detection to Prevention in India

In this article, Mr. Debjit Patra, Chairman & Founder, MediElaj, explores how AI and predictive analytics are revolutionizing healthcare, moving from reactive crisis management to proactive prevention. Amid rising rates of chronic diseases (74% of global deaths), he highlights tools like wearables and ML models that reduce readmissions by 25%, optimize hospital operations and empower […]
Article by: Sony Singh
Vaidam Health’s Vision for Medical Tourism Boom
Featured Article
April 23, 2026

Vaidam Health’s Vision for Medical Tourism Boom

Pankaj Chandna, Co-Founder of Vaidam Health, shares exclusive insights into India’s rising appeal as a global healthcare hub in this interview. With steady double-digit growth in international patients post-pandemic, Vaidam is capitalizing on demand from Africa and Southeast Asia for specialties like oncology, cardiac surgery and organ transplants. He highlights how AI, virtual consultations and […]
Article by: Sony Singh
Redefining the Fight Against AMR: Anti-Virulence Strategies and Phage Therapy Lead the Way
Featured Article
April 21, 2026

Redefining the Fight Against AMR: Anti-Virulence Strategies and Phage Therapy Lead the Way

In the shadow of a mounting antimicrobial resistance (AMR) crisis, India stands at a critical crossroads. With drug-resistant infections claiming nearly 300,000 lives in 2019 alone, according to ICMR data, and resistance rates soaring to 80% for pathogens like carbapenem-resistant Acinetobacter baumannii, traditional antibiotics are losing ground fast. Overuse, inadequate diagnostics, and environmental factors have fueled […]
Article by: Sony Singh